WARSAW, Ind., June 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer is scheduled to participate in a fireside chat at the Truist Securities MedTech Conference, being held in Boston, MA. Event: Truist Securities MedTech Conference Format: Fireside Chat Date: Tuesday, June 18, 2024 Time: 4:45 pm ET An audio we ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...

OrthoPediatrics (KIDS) reported $44.69 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 41.5%. EPS of -$0.30 for the same period compares to -$0.29 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $41.63 million, representing a surprise of +7.35%. The company delivered an EPS surprise of +28.57%, with the consensus EPS estimate being -$0.42.While investors scrutinize revenue and earnings changes year-over-year and how they compare with ...

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 28.57%. A quarter ago, it was expected that this maker of orthopedic devices would post a loss of $0.28 per share when it actually produced a loss of $0.23, delivering a surprise of 17.86%.Over the last four quarters, the ...

OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance First Quarter 2024 Revenue Increased 41% Year-over-Year WARSAW, Ind., May 6, 2024 -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2024. First Quarter 2024 and Business Highlights David Bailey, President & CEO of Or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K [Mark One] ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number 001-38242 ORTHOPEDIATRICS CORP. Common Stock, $0.00025 par value per share KIDS Nasdaq Global Market Title of Each Class Tr ...

Call Start 08:00 January 1, 0000 9:04 AM ET OrthoPediatrics Corp (NASDAQ:KIDS) Q4 2023 Earnings Conference Call March 07, 2024 08:00 AM ET Company Participants Trip Taylor - Investor Relations David Bailey - President and CEO Fred Hite - Chief Operating Officer and CFO Conference Call Participants Matthew O'Brien - Piper Sandler Rick Wise - Stifel Ryan Zimmerman - BTIG Dave Turkaly - Citizens JMP Samuel Brodovsky - Truist Securities Operator Good morning and welcome to OrthoPediatrics Corporation's Fourth Q ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (State or other jurisdic ...

OrthoPediatrics Corp (NASDAQ:KIDS) Q3 2023 Earnings Conference Call November 7, 2023 8:00 AM ET Company Participants Trip Taylor - Investor Relations David Bailey - President and Chief Executive Officer Fred Hite - Chief Operating and Financial Officer Conference Call Participants Matthew O’Brien - Piper Sandler Rick Wise - Stifel Ryan Zimmerman - BTIG Samuel Brodovsky - Truist Securities Operator Good morning, and welcome to the OrthoPediatrics Corporation Third Quarter 2023 Earnings Conference Call. [Oper ...

OrthoPediatrics Corp. (NASDAQ:KIDS) Q2 2023 Earnings Conference Call August 1, 2023 8:00 AM ET Company Participants Trip Taylor - Investor Relations, Gilmartin Group David Bailey - President and Chief Executive Oficer Fred Hite - Chief Financial Officer and Chief Operating Officer Conference Call Participants Ryan Zimmerman - BTIG Matthew O'Brien - Piper Sandler David Saxon - Needham and Company Dave Turkaly - JMP Securities Sam Brodovsky - Truist Securities Operator Good morning, and welcome to OrthoPediat ...